9 / 10
Page 57
conferenceseries
.com
Volume 7, Issue 3 (Suppl)
J Palliat Care Med, an open access journal
ISSN: 2165-7386
Palliative Care 2017
June 21- 22, 2017
3
rd
International Conference on
June 21- 22, 2017 | Philadelphia, USA
Palliative Care & Hospice Nursing
J Palliat Care Med 2017, 7:3(Suppl)
DOI: 10.4172/2165-7386-C1-009
SYSTEMATIC ASSESSMENT AND PATIENTS’ DRUG PRESCRIPTION FOLLOW-UP IN LONG-
TERM CARE
S Medjahed
a
and
D De-Falvelly
a
a
Adelaide Hautval Hospital, France
T
o optimize residents’ drug prescription in long term care, we conducted a retrospective analysis of all patients’ prescriptions
admitted to the department between January 1and June 30 2013. This analysis was to respond, for each drug, to the presence
of an indication of prescription, the appropriateness of the dose and the duration of prescription and to the indication to continue
the prescription beyond the date of evaluation. This analysis was performed independently by two geriatricians, based on the data
contained in the medical records of the patients considered. The justified character of a prescription was defined from the drug
authorizations market data (AMM), the French list of drugs potentially inappropriate in the elderly, indications based on evidence and
certain clinical ethic principles of geriatric medicine. For the 50 drug orders analysed, this approach allowed an average reduction of
three lines of drug prescription per resident. Non-appropriate requirements (indication) rate was 41% of prescriptions; inappropriate
times were 16% of prescriptions and non-adapted doses was 23%.Forty three percent of drug treatments had not been continued. This
systematic evaluation of drug orders on admission is now sustainable in long-term care. This leads to correct drug prescriptions and
fights against poly medication and the avoidable supply in the elderly.